Chemosensitisation of a Drug-sensitive Parental Cell Line by Low-dose Cyclosporin A

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1991 Jan 1

PMID 1742845

Citations 1

Authors

P R Twentyman

K A Wright

Affiliations

Soon will be listed here.

Abstract

We investigated the chemosensitisation of the parental EMT6 mouse mammary tumour cell line by low doses of cyclosporin A (CsA). This cell line has not previously been exposed to cytotoxic drugs but expresses low levels of P-glycoprotein. We produced greater than 2-fold sensitisation to doxorubicin, colchicine and vincristine using 0.084 microM (0.1 micrograms/ml) CsA. Cellular accumulation of doxorubicin and daunorubicin was also increased by this dose. In the MDR subline EMT6/AR1.0, much higher doses of CsA were required to effect optimal restoration of doxorubicin or daunorubicin accumulation. The effects of CsA on the parent line could not be increased by extended preincubation of cells with the sensitiser. These effects of CsA in the EMT6 parent cell line occur at a dose that is 1 order of magnitude lower than those previously reported to produce significant chemosensitisation.

Citing Articles

The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells.

Claudio J, Emerman J Breast Cancer Res Treat. 1996; 41(2):111-22.

PMID: 8944329 DOI: 10.1007/BF01807156.

References

Safa A, Glover C, Sewell J, MEYERS M, Biedler J, Felsted R . Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem. 1987; 262(16):7884-8. View

Coley H, Twentyman P, Workman P . Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Biochem Pharmacol. 1989; 38(24):4467-75. DOI: 10.1016/0006-2952(89)90658-8. View

Goldstein L, Galski H, Fojo A, Willingham M, Lai S, Gazdar A . Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 1989; 81(2):116-24. DOI: 10.1093/jnci/81.2.116. View

Hu X, de Luise M, Martin T, Zalcberg J . Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin. Eur J Cancer. 1990; 26(7):814-7. DOI: 10.1016/0277-5379(90)90159-q. View

Rockwell S, Kallman R, Fajardo L . Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst. 1972; 49(3):735-49. View

Twentyman P, Reeve J, Koch G, Wright K . Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). Br J Cancer. 1990; 62(1):89-95. PMC: 1971747. DOI: 10.1038/bjc.1990.235. View

Dalton W, Grogan T, Meltzer P, Scheper R, Durie B, Taylor C . Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol. 1989; 7(4):415-24. DOI: 10.1200/JCO.1989.7.4.415. View

Twentyman P, Fox N, White D . Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer. 1987; 56(1):55-7. PMC: 2001675. DOI: 10.1038/bjc.1987.153. View

Slater L, Sweet P, Stupecky M, Gupta S . Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest. 1986; 77(4):1405-8. PMC: 424510. DOI: 10.1172/JCI112450. View

10.

Twentyman P . Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival. Br J Cancer. 1980; 42(2):297-304. PMC: 2010392. DOI: 10.1038/bjc.1980.230. View

11.

Sonneveld P, Nooter K . Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br J Haematol. 1990; 75(2):208-11. DOI: 10.1111/j.1365-2141.1990.tb02650.x. View

12.

Chambers S, Bleehen N, Watson J . Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells. Br J Cancer. 1984; 49(3):301-6. PMC: 1976742. DOI: 10.1038/bjc.1984.47. View

13.

Gaveriaux C, Boesch D, Boelsterli J, Bollinger P, Eberle M, Hiestand P . Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. Br J Cancer. 1989; 60(6):867-71. PMC: 2247253. DOI: 10.1038/bjc.1989.381. View

14.

Jones R, Kerr D, Harnett A, Rankin E, Ray S, Kaye S . A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer. Br J Cancer. 1990; 62(1):133-5. PMC: 1971753. DOI: 10.1038/bjc.1990.244. View

15.

Kartner N, Bradley G, Ling V . Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 1985; 316(6031):820-3. DOI: 10.1038/316820a0. View

16.

Juranka P, Zastawny R, Ling V . P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 1989; 3(14):2583-92. DOI: 10.1096/fasebj.3.14.2574119. View

17.

Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y . Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res. 1984; 44(10):4303-7. View

18.

Endicott J, Ling V . The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989; 58:137-71. DOI: 10.1146/annurev.bi.58.070189.001033. View

19.

Reeve J, Rabbitts P, Twentyman P . Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69. Br J Cancer. 1989; 60(3):339-42. PMC: 2247176. DOI: 10.1038/bjc.1989.282. View

20.

Cornwell M, Pastan I, Gottesman M . Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem. 1987; 262(5):2166-70. View